APA (7th ed.) Citation

R, K., MY, P., MA, V., A, P., L, A., JM, M., . . . CL, R. (2026). Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2501441. https://doi.org/10.1200/JCO-25-01441

Chicago Style (17th ed.) Citation

R, Kotecha, et al. "Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 2026: JCO2501441. https://doi.org/10.1200/JCO-25-01441.

MLA (9th ed.) Citation

R, Kotecha, et al. "Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2026, p. JCO2501441, https://doi.org/10.1200/JCO-25-01441.